[1] TÄNGDÉN T, GISKE C.Global dissemination of extensively drug-resistant carbapenemase-producing Enterobacteriaceae:clinical perspectives on detection, treatment and infection control[J].J Intern Med, 2015, 277(5):501. doi: 10.1111/joim.2015.277.issue-5
[2] 胡付品, 朱德妹, 汪复, 等.2014年CHINET中国细菌耐药性监测[J].中国感染与化疗杂志, 2015(5):401. doi: 10.3969/j.issn.1009-7708.2015.05.001
[3] 刘婧娴, 俞静, 李媛睿, 等.肺炎克雷伯菌对碳青霉烯类抗生素的耐药机制研究[J].上海交通大学学报(医学版), 2016, 36(1):93. doi: 10.3969/j.issn.1674-8115.2016.01.019
[4] PATEL JB.Performance standards for antimicrobial susceptibility testing[M].Clin Laborat Stand Instit, 2017.
[5] POIREL L, WALSH TR, CUVILLIER V, et al.Multiplex PCR for detection of acquired carbapenemase genes[J].Diagn Microbiol Infect Dis, 2011, 70(1):119. doi: 10.1016/j.diagmicrobio.2010.12.002
[6] LOGAN LK, WEINSTEIN RA.The epidemiology of carbapenem-resistant Enterobacteriaceae:the impact and evolution of a global menace[J].J Infect Dis, 2017, 215(suppl 1):S28.
[7] MARSH JW, KRAULAND MG, NELSON JS, et al.Genomic epidemiology of an endoscope-associated outbreak of Klebsiella pneumoniae carbapenemase (KPC)-producing K.pneumoniae[J].PLoS One, 2015, 10(12):e0144310. doi: 10.1371/journal.pone.0144310
[8] YIGIT H, QUEENAN AM, RASHEED JK, et al.Carbapenem-resistant strain of Klebsiella oxytoca harboring carbapenem-hydrolyzing β-lactamase KPC-2[J].Antimicrob Agents Chemother, 2003, 47(12):3881. doi: 10.1128/AAC.47.12.3881-3889.2003
[9] ENDIMIANI A, CHOUDHARY Y, BONOMO RA.In vitro activity of NXL104 in combination with β-lactams against Klebsiella pneumoniae isolates producing KPC carbapenemases[J].Antimicrob Agents Chemother, 2009, 53(8):3599. doi: 10.1128/AAC.00641-09
[10] CAMPOS AC, ALBIERO J, ECKER AB, et al.Outbreak of Klebsiella pneumoniae carbapenemase-producing K pneumoniae:a systematic review[J].Am J Infect Control, 2016, 44(11):1374. doi: 10.1016/j.ajic.2016.03.022
[11] OKAMOTO K, LIN MY, HAVERKATE M, et al.Modifiable risk factors for the spread of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae among long-term acute-care hospital patients[J].Infect Control Hosp Epidemiol, 2017, 38(6):670. doi: 10.1017/ice.2017.62
[12] GALLAGHER JC, KURIAKOSE S, HAYNES K, et al.A case-case-control study of patients with carbapenem-resistant and third-generation cephalosporin-resistant Klebsiella pneumoniae bloodstream infections[J].Antimicrob Agents Chemother, 2014, 58(10):5732. doi: 10.1128/AAC.03564-14
[13] 王凤, 赖开生, 安静娜, 等.2013-2017年某三甲医院产KPC肺炎克雷伯菌流行特征研究[J].中华医院感染学杂志, 2017, 27(24):5521.
[14] 赵金云, 许文芳, 金法祥.ICU和非ICU患者感染肺炎克雷伯菌中超广谱β-内酰胺酶和碳青霉烯酶检测[J].中华医院感染学杂志, 2018, 28(2):165.
[15] 凌勇, 肖洪广, 邱芳华.耐碳青霉烯肺炎克雷伯菌的耐药基因分析[J].热带医学杂志, 2018, 18(3):358. doi: 10.3969/j.issn.1672-3619.2018.03.019
[16] PORRECA AM, SULLIVAN KV, GALLAGHER JC.The Epidemiology, Evolution, and Treatment of KPC-Producing Organisms[J].Curr Infect Dis Rep, 2018, 20(6):13. doi: 10.1007/s11908-018-0617-x
[17] 胡仁静, 严子禾, 胡锡池.Carba NP试验及CIM试验检测肠杆菌科细菌碳青霉烯酶的性能评估[J].职业与健康, 2016, 32(23):3208.
[18] 高倩倩, 殷杏, 祝俊英, 等.碳青霉烯类耐药肺炎克雷伯菌的分子特征[J].中国感染与化疗杂志, 2013, 21(9):52.
[19] 林琳, 王晶, 肖晓光, 等.重症病房耐碳青霉烯肺炎克雷伯菌KPC基因检测及同源性分析[J].国际检验医学杂志, 2018, 39(7):798. doi: 10.3969/j.issn.1673-4130.2018.07.009
[20] 杨雪, 刘琳, 赵丹, 等.耐碳青霉烯类肺炎克雷伯菌耐药基因检测与分子流行病学研究[J].重庆医学, 2018(15):1977. doi: 10.3969/j.issn.1671-8348.2018.15.001
[21] 姚欣, 冯莉, 朱艮苗.碳青霉烯类耐药肺炎克雷伯菌分子流行病学及耐药机制[J].中国抗生素杂志, 2018, 43(1):85. doi: 10.3969/j.issn.1001-8689.2018.01.014
[22] FOURNIER PE, DRANCOURT M, COLSON P, et al.Modern clinical microbiology:new challenges and solutions[J].Nat Rev Microbiol, 2013, 11(8):574. doi: 10.1038/nrmicro3068
[23] SANGUINETTI M, POSTERARO B.Mass spectrometry applications in microbiology beyond microbe identification:progress and potential[J].Expert Eev Proteomics, 2016, 13(10):965. doi: 10.1080/14789450.2016.1231578
[24] GIACOMETTI F, PIVA S, VRANCKX K, et al.Application of MALDI-TOF MS for the subtyping of Arcobacter butzleri strains and comparison with their MLST and PFGE types[J].Int J Food Microbiol, 2018, 277:50. doi: 10.1016/j.ijfoodmicro.2018.04.026
[25] LINDGREN Å, KARAMI N, KARLSSON R, et al.Development of a rapid MALDI-TOF MS based epidemiological screening method using MRSA as a model organism[J].Eur J Clin Microbiol Infect Dis, 2018, 37(1):57. doi: 10.1007/s10096-017-3101-x